Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight (CRESSOB)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 430
- 主要终点
- Evolution of modifiable metabolic risk factors (Blood pressure, cigarette smoking, waist perimeter, BMI, glycemia and lipidic profile) in schizophrenic patients with overweight for 12 months.
研究概览
简要总结
To analyse the progress of modifiable metabolic risk factors (Blood pressure, cigarette smoking, waist perimeter, BMI, glycemia and lipidic profile) in schizophrenic patients with overweight for 12 months.
To analyse the perceived health status and the level of functioning and disability of patients with schizophrenia and overweight and their progress at 3, 6 and 12 months.
To assess the progress of the symptoms of the disease at 6 and 12 months.
详细描述
Consecutive patient sampling. Any investigational site four consecutive patients with diagnosis of Schizophrenia (DSM-IV TR) and Overweight (BMI more or equal to 25 Kg/m2)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with diagnosis of schizophrenia, schizophreniform or schizoaffective disorder (DSM-IV TR)
- •Patients with BMI (body mass index) more or equal to 25 Kg/m2
- •Patients or their legal representative have provided written informed consent
排除标准
- •Patients are unable to complete or to understand health questionnaires in Spanish language
- •Patients are currently enrolled on clinical trials or other investigational studies
结局指标
主要结局
Evolution of modifiable metabolic risk factors (Blood pressure, cigarette smoking, waist perimeter, BMI, glycemia and lipidic profile) in schizophrenic patients with overweight for 12 months.
时间窗: 12 months
次要结局
- To assess the progress of the symptoms and clinical evolution of the disease(12 months)
- Patient Functional Impairment(12 months)
- Current Pattern of Treatment in this Population(12 months)
- Cardiovascular Risk(12 months)
- Patient Quality of Life(12 months)